<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">Cerebral vasospasm</z:e> can be defined as delayed-<z:hpo ids='HP_0003674'>onset</z:hpo> narrowing of the cerebral arteries that can occur after a spontaneous aneurysmal <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH) </plain></SENT>
<SENT sid="1" pm="."><plain>Despite a large number of experimental and clinical investigations, the exact pathophysiology of vasospasm remains unknown </plain></SENT>
<SENT sid="2" pm="."><plain>Using a fluorescence differential-display system, we have identified the gene encoding heat shock protein 72 (HSP72) as being highly upregulated by <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We therefore elucidated the role of the HSP72 gene in <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> in a rat experimental SAH model </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS AND RESULTS: By angiography, <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> was detected from day 1, with maximal narrowing detected on day 2 </plain></SENT>
<SENT sid="5" pm="."><plain>Intracisternal injection of antisense HSP72 oligodeoxynucleotide led to specific inhibition of HSP72 gene expression and significantly aggravated <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> on days 2 and 3 of the angiographic studies </plain></SENT>
<SENT sid="6" pm="."><plain>Oral administration of geranylgeranylacetone (GGA), an <z:chebi fb="3" ids="49201">antiulcer drug</z:chebi>, enhanced HSP72 induction and reduced <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: These results suggest HSP72 plays a novel role in antagonizing delayed <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> after SAH and that GGA provides protective effects against delayed <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e>, at least partly via induction of HSP72 </plain></SENT>
</text></document>